11.1 Information on toxicological effects
Acute toxicity
LD50 Oral - Rat - > 16,000 mg/kg
Remarks: (ECHA)
Inhalation: No data available
Dermal: No data available
Skin corrosion/irritation
Skin - In vitro study
Result: No skin irritation - 42 min (Human Skin Model Test)
Remarks: (own results)
Serious eye damage/eye irritation
Eyes - Rabbit
Result: No eye irritation
Remarks: (ECHA)
Respiratory or skin sensitization
Maximisation Test - Guinea pig
Result: negative
Remarks: (ECHA)
Human experience
Result: negative
Remarks: (Lit.)
Germ cell mutagenicity
Test Type: Ames test
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 471
Result: negative
Test Type: HGPRT (cell forward mutation assay)
Metabolic activation: with and without metabolic activation
Result: negative
Remarks: (ECHA)
Test Type: In vivo micronucleus test
Species: Mouse
Cell type: Red blood cells (erythrocytes)
Application Route: Oral
Remarks: (ECHA)
Carcinogenicity
Classified based on available data. For more details, see section 2
Reproductive toxicity
Classified based on available data. For more details, see section 2
Specific target organ toxicity - single exposure
Classified based on available data. For more details, see section 2
Specific target organ toxicity - repeated exposure
Classified based on available data. For more details, see section 2
Aspiration hazard
Classified based on available data. For more details, see section 2
11.2 Additional Information
Repeated dose toxicity - Rat - male and female - Oral - No observed adverse effect level - 450 mg/kg
Remarks: (ECHA)
Repeated dose toxicity - Rat - male and female - Dermal - No observed adverse ef- fect level - 360 mg/kg
Remarks: (ECHA)
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.